Omega-3 Supplement Formulation: Oil Quality, Oxidation & Softgel Design

Omega-3 supplement formulation begins with two essential specifications: the EPA and DHA amounts required per serving. These targets guide oil selection and capsule fill weight, but they do not determine whether the finished product will remain stable.

Oil purity, oxidative stability, shell compatibility, and packaging also influence manufacturing performance. A concentrated fish oil may reduce the required fill, yet an unsuitable EPA ratio or incompatible capsule shell can create problems during production.

A manufacturing-ready omega-3 softgel must deliver verified EPA/DHA potency, meet appropriate oxidation specifications, and maintain acceptable capsule integrity throughout its intended shelf life.

This guide explains how supplement brands can connect oil specifications, fatty acid calculations, oxidation testing, softgel design, quality documentation, and commercial manufacturing requirements.

From Omega-3 Formula to Manufacturing Specifications

A manufacturing-ready omega-3 formula requires defined active levels, raw material specifications, processing requirements, and finished-product acceptance criteria.

Development begins with the intended EPA and DHA amounts per serving. These targets determine which oil concentrations and fatty acid ratios are suitable.

The selected oil then influences capsule fill volume, serving count, manufacturing cost, and potentially the choice of softgel shell.

Before prototype development, manufacturers should establish:

• EPA/DHA targets: Individual fatty acid amounts per serving.
• Oil specifications: Source, molecular form, concentration, oxidation quality, and purity.
• Softgel requirements: Fill weight, capsule dimensions, shell material, and sealing performance.
• Stability controls: Antioxidant strategy, processing conditions, and packaging protection.
• Quality requirements: Appropriate analytical methods, acceptance criteria, and batch documentation.

These specifications provide a consistent starting point for material sourcing, prototype testing, and commercial manufacturing.

If one parameter creates a conflict, such as excessive fill weight or poor shell compatibility, the development team can compare alternative materials and dosage configurations before committing to larger production volumes.

Choosing the Right Omega-3 Oil

Oil selection influences EPA/DHA delivery, capsule size, oxidative stability, and product positioning.

The highest concentration is not always the best choice. A suitable oil must provide the required fatty acid ratio while meeting specifications for purity, traceability, oxidation, and cost.

Fish Oil, Algal Oil, and Krill Oil

Fish oil is commonly used in conventional EPA/DHA supplements. Its fatty acid composition varies according to the biological source and processing method. Concentrated grades may reduce the amount of oil required per serving.

Algal oil provides an alternative for vegetarian-oriented omega-3 products. Many commercial grades are DHA-rich, while selected sources offer EPA or combined EPA/DHA.

Krill oil contains omega-3 fatty acids associated with phospholipids and other lipid components. Its composition and analytical requirements differ from those of conventional refined fish oils.

Each source should be evaluated against the intended product specification rather than generalized claims about superior quality or absorption.

Triglycerides, Ethyl Esters, and Re-Esterified Triglycerides

Omega-3 oils may be supplied in different molecular forms.

Triglycerides (TG) contain fatty acids attached to a glycerol backbone and occur naturally in many fish oils.

Ethyl esters (EE) are produced by converting fatty acids into ethyl ester derivatives, commonly during oil concentration.

Re-esterified triglycerides (rTG) are formed when concentrated ethyl ester fatty acids are converted back into triglyceride structures.

The NIH Office of Dietary Supplements explains that certain omega-3 forms can show modest bioavailability advantages over ethyl esters under specific conditions. However, all these forms can increase circulating EPA and DHA levels.

For commercial development, molecular form should be considered alongside fatty acid concentration, ingredient specifications, supply consistency, and cost.

Oil Purity and Supplier Qualification

An omega-3 oil specification should identify the biological source, manufacturing origin, fatty acid composition, molecular form, oxidation results, and relevant contaminant limits.

Depending on the ingredient and destination market, supplier documentation may include testing for PCBs, dioxins, furans, and heavy metals.

A Certificate of Analysis (COA) should identify the batch, analytical methods, measured results, reporting units, and acceptance criteria.

Essencefield’s ingredient sourcing process covers specification review, supplier qualification, documentation, sample evaluation, and commercial supply planning.

For omega-3 projects, these steps help brands compare candidate oils before selecting materials for prototype production.

Calculating EPA/DHA Content and Softgel Fill Weight

EPA and DHA should be calculated separately when a supplement has individual fatty acid targets.

Two oils with the same combined EPA+DHA concentration may require different fill weights because their fatty acid ratios differ.

Total Fish Oil vs. EPA/DHA Content

A 1,000 mg fish oil softgel does not necessarily provide 1,000 mg of EPA and DHA.

A conventional fish oil may contain approximately 180 mg EPA and 120 mg DHA per 1,000 mg of oil.

That represents 300 mg combined EPA+DHA, or approximately 30% of the total oil weight.

Concentrated oils may provide higher proportions, but their individual EPA and DHA concentrations must be verified before calculating the required fill.

Calculating Oil Requirements

For a product with minimum individual fatty acid targets:

Required oil mass (mg) = The greater of:

• Target EPA (mg) ÷ EPA mass fraction
• Target DHA (mg) ÷ DHA mass fraction

Consider a hypothetical supplement designed to provide at least 400 mg EPA and 200 mg DHA per serving.

Three candidate oils each contain 60% combined EPA+DHA, but their ratios differ.

Oil A meets both targets with 1,000 mg of oil.

Oil B requires approximately 1,333 mg to deliver 400 mg EPA, also supplying approximately 400 mg DHA.

Oil C requires 2,000 mg to meet the EPA target, delivering approximately 800 mg DHA.

Although all three oils contain 60% combined EPA+DHA, Oil A offers the closest match to the specified individual minimums.

If the product requires a narrower EPA ratio rather than minimum amounts, the formulator may need a different oil or a carefully designed blend.

When the calculated fill exceeds the preferred capsule capacity, higher-concentration oils, larger capsules, or multiple softgels per serving should be compared before prototype development.

These are hypothetical engineering calculations, not actual supplier specifications. Commercial calculations must account for additional fill ingredients, assay conventions, raw material variability, processing losses, and justified manufacturing tolerances.

Reconciling EPA/DHA Assay Results with Fill-Weight Calculations

Before calculating fill weight, confirm how the supplier reports EPA and DHA.

Results expressed as mg/g of oil, weight percentages, and chromatographic area percentages are not automatically interchangeable.

For example, a reported EPA value of 40% may describe its proportion within the measured fatty acid profile rather than 40% of the entire oil mass.

The American Oil Chemists’ Society (AOCS) GOED laboratory program distinguishes quantitative fatty acid measurements reported in mg/g from fatty acid composition expressed as chromatographic area percentages.

Before finalizing a formula, confirm whether the assay represents actual mass per gram of oil, free fatty acid equivalents, or another reporting basis.

If the supplier’s COA does not establish a suitable quantitative basis, obtain clarification or additional analytical data.

Converting Fill Weight to Capsule Volume

Capsule capacity depends on fill volume as well as mass.

Fill volume (mL) = Fill mass (g) ÷ Fill density (g/mL)

For example, assuming a fill density of 0.92 g/mL:

1.00 g ÷ 0.92 g/mL = approximately 1.09 mL

The manufacturer must verify that the calculated volume is compatible with the intended capsule geometry, tooling, shell material, and filling process.

Higher EPA/DHA concentration can reduce fill weight, but it does not necessarily reduce total production cost.

Brands should compare ingredient cost per serving, capsule count, shell materials, processing, testing, and packaging.

These decisions can be addressed during custom supplement formulation before selecting the final dosage configuration.

Measuring Omega-3 Oxidation: PV, p-AV, and TOTOX

Fish oil oxidation is a major quality consideration because EPA and DHA are highly unsaturated fatty acids.

Oxygen, heat, light, and certain catalytic contaminants can accelerate lipid oxidation. Primary oxidation produces lipid hydroperoxides, which may subsequently decompose into secondary compounds, including aldehydes.

These changes can affect odor, flavor, and chemical stability.

Understanding the Main Oxidation Indicators

Three measurements are commonly used to evaluate oxidation in applicable omega-3 oils.

TOTOX = (2 × PV) + p-AV

These limits appear in the GOED Voluntary Monograph, Version 8.1, issued January 6, 2022.

The monograph covers defined bulk refined oils and qualifying finished liquid or encapsulated omega-3 oils. Its specifications apply throughout the stated shelf life.

Certain special delivery systems, oils below the monograph’s omega-3 concentration threshold, and specified lipid matrices fall outside its scope.

Flavored oils can remain within the monograph’s scope when their underlying oil qualifies. However, conventional p-AV and TOTOX limits are not applicable to flavored oils because flavor ingredients can interfere with p-anisidine measurements.

These limits are voluntary industry specifications, not universal legal requirements for every omega-3 supplement or destination market.

Why Oxidation Results Require Interpretation

PV measures hydroperoxides associated with primary oxidation.

Because these compounds can decompose over time, a low PV does not necessarily demonstrate minimal oxidation.

p-AV provides complementary information about selected secondary oxidation products, while TOTOX combines both measurements.

Neither test measures every possible degradation compound.

Results should be assessed alongside the oil’s composition, processing history, method suitability, and established quality specifications.

Acid Value and Oxidation Measure Different Changes

Acid Value (AV) measures the amount of base required to neutralize acidic components in an oil. It can provide information related to free fatty acids and hydrolytic changes.

However, hydrolysis and oxidation are different chemical processes.

An elevated acid value does not by itself establish that an oil has high peroxide or secondary oxidation levels.

Where AV forms part of the approved material specification, its result should be assessed separately from the oxidation indicators.

Oxidation Testing in Flavored Oils

Flavor compounds may interfere with conventional p-anisidine testing.

Research published by Ye and colleagues in the Journal of the American Oil Chemists’ Society examined how added flavors influenced p-AV results during storage.

The researchers found that flavor contributions could change over time, complicating the interpretation of conventional measurements.

The study, Flavors’ Decreasing Contribution to p-Anisidine Value over Shelf Life, illustrates why analytical methods should be selected according to the actual product matrix.

For flavored formulations, manufacturers should establish suitable testing approaches and use complementary evidence where necessary.

What Published Product Testing Shows

Research on commercial omega-3 supplements demonstrates the importance of finished-product verification.

A 2015 Canadian-market study of 171 omega-3 supplements found that approximately half of the products successfully tested exceeded at least one voluntary oxidation reference limit.

A separate 2020 U.S. study of 48 retail EPA/DHA supplements reported that most products met the relevant oxidation criteria assessed, while identifying analytical variability and limitations in comparing certain formulations.

The studies used different samples and testing conditions. Their findings should not be combined into an estimate of current market quality.

For manufacturers, they demonstrate the importance of selecting appropriate analytical methods and verifying finished-product performance rather than relying exclusively on incoming oil results.

Preventing Oxidation During Manufacturing

Oxidation prevention begins with incoming oil quality and continues through blending, encapsulation, drying, and packaging.

Mixed tocopherols are commonly considered for oxidation-sensitive lipid systems, although their effectiveness depends on oil composition, concentration, processing conditions, and other formulation components.

Antioxidants can help slow deterioration, but they cannot reliably restore oil that has already undergone extensive oxidation.

Managing Oxygen and Processing Exposure

Manufacturing controls may include:

• Closed or appropriately protected oil transfer
• Nitrogen blanketing where technically suitable
• Controlled mixing to limit unnecessary air incorporation
• Defined oil holding times
• Protection from excessive heat and light
• Suitable transfer equipment and storage containers

The appropriate controls depend on the manufacturing process.

For example, prolonged blending in a partially filled vessel may create different oxygen-exposure conditions than short-duration processing in a closed system.

Process records and suitable testing help establish whether the selected controls are effective.

Managing Fishy Odor and Sensory Quality

Fishy odor and aftertaste are important product attributes, but they are not direct measurements of oxidation.

Sensory characteristics may reflect the starting oil, volatile compounds, capsule release behavior, flavor ingredients, and storage conditions.

A study published in Lipids, Key Lipid Oxidation Products Can Be Used to Predict Sensory Quality of Fish Oils, found that conventional chemical oxidation measurements do not necessarily correlate closely with sensory characteristics.

During prototype development, manufacturers can assess odor, capsule appearance, leakage, and relevant sensory changes alongside chemical testing.

Flavoring or modified-release designs may be considered for specific product objectives, but their performance should be verified rather than assumed.

Adding flavor ingredients may also require reassessment of the analytical methods used to evaluate oxidation.

Oxidation Troubleshooting

Unexpected oxidation results should trigger a documented investigation rather than an immediate assumption about the cause.

These are investigation directions rather than definitive diagnoses.

Conclusions should be based on appropriate analytical methods, batch records, specifications, and representative sampling.

Softgel Shell Compatibility and Common Failure Modes

Softgels are widely used for omega-3 oils because they provide a sealed dosage form for liquid lipid fills.

However, fill-shell compatibility, moisture balance, capsule geometry, and seam integrity influence finished-product performance.

Gelatin and Vegetarian Shell Selection

Gelatin is commonly used for conventional oil-filled softgels because its forming and sealing characteristics are well established.

Vegetarian softgel systems may use selected plant-derived polymers, including starch- or carrageenan-based materials. Their processing characteristics and moisture requirements can differ from gelatin.

For vegetarian algal oil products, shell composition and supporting documentation should match the intended positioning and label claims.

Essencefield’s softgel manufacturing service describes development considerations involving oil-based fills, shell compatibility, encapsulation, sealing, drying, and packaging.

Common Softgel Manufacturing Problems

Certain lipid oxidation products can interact with gelatin under specific conditions and contribute to changes in shell performance.

Shell material selection should therefore consider the oil formulation, drying conditions, expected storage environment, and relevant release characteristics.

Any proposed shell system should undergo product-specific compatibility evaluation.

Packaging and Shelf-Life Stability

Packaging affects oxygen, light, moisture, and environmental exposure after encapsulation.

Bottle performance depends on container material, closure integrity, light protection, and headspace conditions.

Blister performance depends on forming and lidding materials, seal integrity, and the barrier properties of each cavity.

Blister packaging can reduce repeated exposure of unopened units, while bottles provide flexible capsule counts and packaging configurations.

Selection should follow the product’s stability requirements and intended distribution environment.

Stability Testing Priorities

A risk-based stability program may evaluate:

• EPA/DHA potency
• Applicable oxidation indicators
• Capsule leakage and physical integrity
• Shell appearance and disintegration
• Packaging performance
• Relevant sensory changes

Accelerated testing can help identify potential degradation pathways. Real-time stability studies provide important evidence of performance during the intended shelf life.

A declared expiration date should be supported by appropriate stability data, including the actual commercial packaging configuration.

For brands planning retail or e-commerce distribution, Essencefield’s supplement packaging and labeling service covers container selection, blister configurations, barrier requirements, sealing, coding, and packaging coordination.

Omega-3 Quality Control and COA Review

An incoming oil COA supports supplier qualification, but it does not independently establish the quality of the finished softgel.

Quality verification should connect raw material acceptance, manufacturing controls, appropriate testing, and batch release documentation.

How to Review an Omega-3 Oil COA

The GOED Monograph expresses EPA and DHA as free fatty acid equivalents for comparisons across applicable oil forms.

When suppliers use different reporting conventions, buyers should establish a consistent basis before comparing potency or calculating fill weight.

Supplier COA vs. Finished-Product Verification

A supplier COA describes the incoming material.

Manufacturing records document relevant processing controls, while finished-product verification helps establish whether the completed dosage form meets its approved specifications.

Under U.S. 21 CFR 111.75, dietary supplement manufacturers must determine whether applicable component, in-process, and finished-batch specifications are met through appropriate controls and scientifically valid testing or examinations.

Testing scope and frequency should reflect the formulation, process risks, product specifications, and regulatory requirements.

Essencefield’s quality control and testing approach describes coordinated review of materials, production checkpoints, laboratory testing, documentation, and batch release.

Maintaining Quality When Changing Oil Suppliers

Changing suppliers can affect a formula even when the replacement oil has the same declared total EPA+DHA concentration.

Different materials may vary in EPA ratio, molecular form, density, antioxidant system, oxidation profile, odor, or analytical reporting basis.

Before approving a replacement, compare the new COA with the established raw material specification and assess whether the change affects fill-weight calculations, capsule performance, labeling, or stability.

Where differences are significant, additional sampling, compatibility testing, or pilot production may be necessary.

Documented supplier change control helps preserve product consistency across repeat commercial batches.

Preparing an Omega-3 Softgel Manufacturing Brief

A clear manufacturing brief helps supplement brands communicate technical requirements and compare proposals using consistent specifications.

It should define EPA/DHA targets, oil characteristics, capsule format, quality requirements, packaging, destination market, and commercial scope.

Omega-3 Softgel RFQ Template

This is an illustrative technical brief, not an existing Essencefield product specification or a guarantee of particular manufacturing quantities or capabilities.

Labeling, Allergen, and Claims Review Before Launch

Commercial readiness also requires reviewing the proposed product label against the destination market’s requirements.

For U.S. dietary supplements, the FDA Dietary Supplement Labeling Guide explains requirements for Supplement Facts, serving size, and dietary ingredient declarations.

Brands should verify that declared EPA/DHA content is supported by appropriate analytical data and that the label identifies relevant oil sources and capsule ingredients correctly.

Allergen review is particularly important for fish oil, krill oil, and other ingredients derived from potential allergen sources.

FDA’s Food Allergies guidance addresses major food allergens and relevant labeling requirements. Qualifying highly refined oils may be excluded from the statutory definition of a major food allergen, but that exclusion should not be assumed for every marine oil.

Marketing claims also require review.

FDA’s Structure/Function Claims guidance explains the applicable substantiation, labeling, and notification requirements. Ordinary dietary supplement claims should not be presented as unsupported disease-treatment claims.

These reviews should be completed before final artwork approval and commercial release.

From Prototype to Commercial Production

Prototype development helps establish whether the intended oil fill, capsule shell, and serving configuration are technically feasible.

Pilot production can reveal differences in filling consistency, sealing, drying, yield, or process behavior that were not apparent during small-scale trials.

Before scale-up, the development team should confirm approved raw materials, manufacturing procedures, quality criteria, packaging specifications, and project responsibilities.

Essencefield’s pilot run and scale-up service supports evaluation of processing behavior, production consistency, yield, and readiness for larger commercial batches.

Working With Essencefield Supplements

Essencefield Supplements supports B2B supplement projects through custom formulation, ingredient sourcing, dosage-form development, manufacturing, quality coordination, and packaging.

For omega-3 projects, the initial technical discussion can begin with individual EPA and DHA targets, preferred oil characteristics, capsule requirements, target market, and estimated production volume.

Specific ingredient grades, shell systems, testing arrangements, order quantities, and production timelines should be confirmed against each project’s requirements.

Conclusion: Building a Stable Omega-3 Softgel

A reliable omega-3 softgel begins with separate EPA and DHA targets and an oil specification that supports practical capsule filling.

Oxidation control, sensory evaluation, shell compatibility, and packaging validation help establish whether the finished product can maintain its intended quality throughout manufacturing and storage.

For supplement brands, these decisions provide a stronger basis for supplier qualification, prototype development, regulatory review, and commercial production.

Planning an omega-3 softgel project? Contact Essencefield Supplements to discuss your ingredient specifications, EPA/DHA targets, capsule design, packaging, and manufacturing requirements.